Literature DB >> 26455830

Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.

Lin Liu1, Qingqing Lou1, Xiaohui Guo2, Li Yuan3, Li Shen4, Zilin Sun5, Fang Zhao6, Xia Dai7, Jin Huang8, Huiying Yang9, John P Mordes10.   

Abstract

BACKGROUND: The prevalence of type 2 diabetes in China is increasing rapidly. Appropriate management of glycemia, blood pressure and dyslipidemia in this population is a major public health concern.
OBJECTIVE: The aim of this study was to assess metabolic control including glycated hemoglobin A1c (HbA1c ), blood pressure (BP) and low density lipoprotein cholesterol (LDL-c), in a large sample of patients with type 2 diabetes in China and to identify factors that correlated with the achievement of HbA1c, BP and LDL-c goals (ABCs).
METHOD: A nationwide survey was conducted in 50 medical centres across China from April to July of 2010. Baseline information on demographics, medical history, HbA1c , BP and LDL-c levels were measured in 5961 patients with type 2 diabetes.
RESULTS: Mean age, body mass index (BMI) and HbA1c were 59.5 ± 1.3 years, 24.5 ± 4.1 kg/m(2) and 8.3 ± 2.2%, respectively. With respect to generally accepted ABC treatment goals, 35.2% of participants had HbA1c <7%; 35.5% had BP < 140/80 mmHg, and 45.1% had LDL-c < 100 mg/dl. The proportion of patients who met all three targets was only 5.4%. Logistic regression revealed that smoking (P=0.000), higher BMI (P=0.001) and insulin use (P=0.000) were statistically significant predictors of failing to meet ABC targets.
CONCLUSION: The percentage of Chinese patients with type 2 diabetes who met recommended targets for HbA1c , BP and LDL-c in 2010 was low. Smoking, higher BMI and insulin use were the strongest determinants of failing to meet ABC targets.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  blood pressure; cholesterol; hemoglobin A1c; type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26455830     DOI: 10.1002/dmrr.2757

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  11 in total

Review 1.  More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity.

Authors:  Chunlan Zhang; Jingjing Zhang; Zhenqi Liu; Zhiguang Zhou
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

2.  Current status of treatment of type 2 diabetes mellitus in Ningbo, China.

Authors:  Tianmeng Yang; Rongjiong Zheng; Qingmei Chen; Yushan Mao
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

Review 3.  Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination.

Authors:  Kimberly N Walter; Julie A Wagner; Eda Cengiz; William V Tamborlane; Nancy M Petry
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

4.  Association of PON2 Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population.

Authors:  Huan Ren; Sheng-Lan Tan; Mou-Ze Liu; Hoan L Banh; Jian-Quan Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-27       Impact factor: 5.555

5.  The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study.

Authors:  Dirk J Blom; Raul D Santos; Veronique Daclin; Florence Mercier; Alvaro J Ruiz; Nicolas Danchin
Journal:  Eur J Prev Cardiol       Date:  2019-09-19       Impact factor: 7.804

6.  Effects of an Outpatient Diabetes Self-Management Education on Patients with Type 2 Diabetes in China: A Randomized Controlled Trial.

Authors:  Fan Zheng; Suixin Liu; Yuan Liu; Lihua Deng
Journal:  J Diabetes Res       Date:  2019-01-17       Impact factor: 4.011

7.  Status of glycosylated hemoglobin and prediction of glycemic control among patients with insulin-treated type 2 diabetes in North China: a multicenter observational study.

Authors:  Jiao Wang; Meng-Yang Wang; Hui Wang; Hong-Wei Liu; Rui Lu; Tong-Qing Duan; Chang-Ping Li; Zhuang Cui; Yuan-Yuan Liu; Yuan-Jun Lyu; Jun Ma
Journal:  Chin Med J (Engl)       Date:  2020-01-05       Impact factor: 2.628

8.  Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.

Authors:  Bruno Linetzky; Brad Curtis; Gustavo Frechtel; Renan Montenegro; Miguel Escalante Pulido; Oded Stempa; Janaina Martins de Lana; Juan José Gagliardino
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

9.  Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China.

Authors:  Jialin Li; Kaushik Chattopadhyay; Miao Xu; Yanshu Chen; Fangfang Hu; Jianping Chu; Li Li
Journal:  BMJ Open       Date:  2018-03-25       Impact factor: 2.692

10.  Organisational and individual characteristics associated with glycaemic control among patients with type 2 diabetes: cross-sectional study in China.

Authors:  Haipeng Wang; Jingjing Yao; Xiao Yin; Xiaolei Guo; Jia Yin; Haiyan Qu; Qiang Sun
Journal:  BMJ Open       Date:  2020-04-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.